Kelly G Paulson1, Song Youn Park2, Natalie A Vandeven2, Kristina Lachance2, Hannah Thomas2, Aude G Chapuis1, Kelly L Harms3, John A Thompson1, Shailender Bhatia1, Andreas Stang4, Paul Nghiem5. 1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Divisions of Medical Oncology and Dermatology, Department of Medicine, University of Washington, Seattle, Washington. 2. Divisions of Medical Oncology and Dermatology, Department of Medicine, University of Washington, Seattle, Washington. 3. Department of Dermatology, University of Michigan, Ann Arbor, Michigan. 4. Center of Clinical Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany. 5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Divisions of Medical Oncology and Dermatology, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: pnghiem@uw.edu.
Abstract
BACKGROUND: Merkel cell carcinoma (MCC) incidence rates are rising and strongly age-associated, relevant for an aging population. OBJECTIVE: Determine MCC incidence in the United States and project incident cases through the year 2025. METHODS: Registry data were obtained from the SEER-18 Database, containing 6600 MCC cases. Age- and sex-adjusted projections were generated using US census data. RESULTS: During 2000-2013, the number of reported solid cancer cases increased 15%, melanoma cases increased 57%, and MCC cases increased 95%. In 2013, the MCC incidence rate was 0.7 cases/100,000 person-years in the United States, corresponding to 2488 cases/year. MCC incidence increased exponentially with age, from 0.1 to 1.0 to 9.8 (per 100,000 person-years) among age groups 40-44 years, 60-64 years, and ≥85 years, respectively. Due to aging of the Baby Boomer generation, US MCC incident cases are predicted to climb to 2835 cases/year in 2020 and 3284 cases/year in 2025. LIMITATIONS: We assumed that the age-adjusted incidence rate would stabilize, and thus, the number of incident cases we projected might be an underestimate. CONCLUSION: An aging population is driving brisk increases in the number of new MCC cases in the United States. This growing impact combined with the rapidly evolving therapeutic landscape warrants expanded awareness of MCC diagnosis and management.
BACKGROUND:Merkel cell carcinoma (MCC) incidence rates are rising and strongly age-associated, relevant for an aging population. OBJECTIVE: Determine MCC incidence in the United States and project incident cases through the year 2025. METHODS: Registry data were obtained from the SEER-18 Database, containing 6600 MCC cases. Age- and sex-adjusted projections were generated using US census data. RESULTS: During 2000-2013, the number of reported solid cancer cases increased 15%, melanoma cases increased 57%, and MCC cases increased 95%. In 2013, the MCC incidence rate was 0.7 cases/100,000 person-years in the United States, corresponding to 2488 cases/year. MCC incidence increased exponentially with age, from 0.1 to 1.0 to 9.8 (per 100,000 person-years) among age groups 40-44 years, 60-64 years, and ≥85 years, respectively. Due to aging of the Baby Boomer generation, US MCC incident cases are predicted to climb to 2835 cases/year in 2020 and 3284 cases/year in 2025. LIMITATIONS: We assumed that the age-adjusted incidence rate would stabilize, and thus, the number of incident cases we projected might be an underestimate. CONCLUSION: An aging population is driving brisk increases in the number of new MCC cases in the United States. This growing impact combined with the rapidly evolving therapeutic landscape warrants expanded awareness of MCC diagnosis and management.
Authors: Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker Journal: J Virol Date: 2010-05-05 Impact factor: 5.103
Authors: Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2017-03-01 Impact factor: 508.702
Authors: Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem Journal: J Clin Oncol Date: 2011-03-21 Impact factor: 44.544
Authors: Harri Sihto; Tom Böhling; Heli Kavola; Virve Koljonen; Marko Salmi; Sirpa Jalkanen; Heikki Joensuu Journal: Clin Cancer Res Date: 2012-03-30 Impact factor: 12.531
Authors: Michelle Heath; Natalia Jaimes; Bianca Lemos; Arash Mostaghimi; Linda C Wang; Pablo F Peñas; Paul Nghiem Journal: J Am Acad Dermatol Date: 2008-03 Impact factor: 11.527
Authors: Gery P Guy; Cheryll C Thomas; Trevor Thompson; Meg Watson; Greta M Massetti; Lisa C Richardson Journal: MMWR Morb Mortal Wkly Rep Date: 2015-06-05 Impact factor: 17.586
Authors: Kelly G Paulson; Jayasri G Iyer; Astrid Blom; E Margaret Warton; Monica Sokil; Lola Yelistratova; Louise Schuman; Kotaro Nagase; Shailender Bhatia; Maryam M Asgari; Paul Nghiem Journal: J Invest Dermatol Date: 2012-11-29 Impact factor: 8.551
Authors: Rocio Garcia-Carbonero; Ivan Marquez-Rodas; Luis de la Cruz-Merino; Javier Martinez-Trufero; Miguel Angel Cabrera; Jose Maria Piulats; Jaume Capdevila; Enrique Grande; Salvador Martin-Algarra; Alfonso Berrocal Journal: Oncologist Date: 2019-04-08
Authors: T Akaike; J Qazi; A Anderson; F S Behnia; M M Shinohara; G Akaike; D S Hippe; H Thomas; S R Takagishi; K Lachance; S Y Park; E S Tarabadkar; J G Iyer; A Blom; U Parvathaneni; H Vesselle; P Nghiem; S Bhatia Journal: Br J Dermatol Date: 2020-06-16 Impact factor: 9.302
Authors: Phyu P Aung; Edwin Roger Parra; Souptik Barua; Dawen Sui; Jing Ning; Barbara Mino; Debora Alejandra Ledesma; Jonathan L Curry; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Eleni Efstathiou; Anh G Hoang; Michael K Wong; Jennifer A Wargo; Alexander J Lazar; Arvind Rao; Victor G Prieto; Ignacio Wistuba; Michael T Tetzlaff Journal: Clin Cancer Res Date: 2019-02-26 Impact factor: 12.531
Authors: Matthew C Perez; Felipe R de Pinho; Amanda Holstein; Daniel E Oliver; Syeda M H Naqvi; Youngchul Kim; Jane L Messina; Erin Burke; Ricardo J Gonzalez; Amod A Sarnaik; C Wayne Cruse; Evan J Wuthrick; Louis B Harrison; Vernon K Sondak; Jonathan S Zager Journal: Ann Surg Oncol Date: 2018-08-02 Impact factor: 5.344